CIK 0001559053 · Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 011-353-1-236-2500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-27 | Garren Hideki Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-02-21 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +132,000 | 132,000 | ||
| 2024-01-24 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $13.53 | $68K | 5,000 |
| 2024-01-24 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −5,000 | $34.00 | $170K | 0 |
| 2024-01-24 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 15,000 | ||
| 2023-12-20 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $13.53 | $68K | 5,000 |
| 2023-12-20 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −1,678 | $36.68 | $62K | 3,322 |
| 2023-12-20 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −3,322 | $37.45 | $124K | 0 |
| 2023-12-20 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 20,000 | ||
| 2023-11-30 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $13.53 | $68K | 5,000 |
| 2023-11-30 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −5,000 | $34.00 | $170K | 0 |
| 2023-11-30 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 25,000 | ||
| 2023-10-25 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $13.53 | $68K | 5,000 |
| 2023-10-25 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −1,789 | $40.27 | $72K | 3,211 |
| 2023-10-25 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −2,917 | $41.38 | $121K | 294 |
| 2023-10-25 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −294 | $42.28 | $12K | 0 |
| 2023-10-25 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 30,000 | ||
| 2023-10-11 | Smith Brandon S. Chief Operating Officer | Option exercise 10b5-1 | +4,000 | $11.12 | $44K | 4,000 |
| 2023-10-11 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −3,556 | $46.62 | $166K | 444 |
| 2023-10-11 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −444 | $47.74 | $21K | 0 |
Page 7 of 9 · 172 trades